November 25, 2016 - By Ellis Scott
Interested investors have been looking for information on shares of NUTRA PHARMA CORPORATION (OTCMKTS:NPHC) after the stock moved $-0.0012, hitting the $0.012 price point in a recent trade.
It’s the latest price, but let’s analyze how the stock has been doing recently. In the past year, NUTRA PHARMA CORPORATION’s stock was big mover. According to the short interest report published recently, (NPHC) had 470,200 shorted shares for 0.1 days to cover. The prior short interest was 8,000 for a $5777.50 change. The 52-Week High and Low are noted here. -90.00% (High), 20.00%, (Low). The stock had 5.17M average volume.
Enroll for Our Newsletter Today and know if shares price of NUTRA PHARMA CORPORATION (OTCMKTS:NPHC) is Ready to Breakout!
Penny stocks are often stated as risky investments that hardly pay off. Admittedly, there is fact to this, but with the right knowledge and tactics, it is possible to earn a significant amount of gain in penny stocks. Simply said, a penny stock is an equity that trades at a low price.
Irrespective of the name, penny stocks usually are priced over a penny, occupying a price range at or close to $1, though some are priced a fraction of a penny. Often referred to as micro-cap equities, the Securities & Exchange Commission classifies these types of securities as being $5 or less. Over-the-counter stocks are NOT listed on any of the formal exchanges.
So, penny stocks frequently fit in this segment, though many dodge this category. Over-the-counter (OTC) equities are stated to be risky as they aren’t contingent to the listing and reporting requirements of the reputed commodity exchanges.
Register in the Bar Below to Obtain Breaking Alerts on Shares That Are Set to Make a Move!
Penny shares can be listed on NASDAQ or other known stock exchanges, although many more cannot be found there. A major percentage of penny stocks are listed on the so-named ‘pink sheets’, i.e., daily news of OTC shares. They can even be seen on the ‘Over-the-Counter Bulletin Board.’ Commodities listed on the OTCBB fail to fulfill the listing guidelines of the NYSE or other known exchanges, although they are mandated to file financial statements with known regulators, such as the SEC. Penny shares are inexpensive, thus attractive to shareholders who lack the funds to buy comparatively expensive blue-chip stocks from large firms.
Penny stocks boast immense profit potential. Because these stocks trade cheap, even a slight jump in price turns to be profitable. Look out, however, because frequently shareholders may have trouble getting a decent amount of details about penny stocks. These kinds of shares tend to be latest in news, with almost no track record for investors research.
In addition, penny stocks show lack of market activity, with poor liquidity, making them difficult to sell. Poor liquidity results in penny stocks to be open to price influence.
A shady trader can simply buy large sums of shares, temporarily leading up the price, crafting artificial demand.
Disclaimer: Nothing mentioned in this publication is planned to constitute legal, securities, tax, or investment advice, nor a viewpoint regarding the relevance of any investment, nor any type of solicitation. The general information mentioned in this article should not be acted upon without getting specific tax, legal and investment advice from a certified professional.
More notable recent Nutra Pharma Corp. (OTCMKTS:NPHC) news were published by: Livetradingnews.com which released: “Nutra Pharma Corp. (OTCMKTS:NPHC) To Move Higher” on November 22, 2016, also Livetradingnews.com with their article: “Nutra Pharma Corp. (OTCMKTS:NPHC) Treatment of HIV, Arthritis, MS” published on September 02, 2016, Livetradingnews.com published: “Nutra Pharma Corp. (OTCMKTS:NPHC) a Bargain” on August 22, 2016. More interesting news about Nutra Pharma Corp. (OTCMKTS:NPHC) were released by: Livetradingnews.com and their article: “Nutra Pharma Corp. (OTCMKTS:NPHC) a BioTech in Multi Billion Dollar Pet Care …” published on October 03, 2016 as well as Livetradingnews.com‘s news article titled: “Nutra Pharma Corp. (OTCMKTS:NPHC) Ready to Break Out” with publication date: October 26, 2016.
Nutra Pharma Corp. is a biopharmaceutical company. The company has a market cap of $2.20 million. The Firm is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. It currently has negative earnings. The Company’s subsidiary and drug discovery arm, ReceptoPharm, Inc. , carries its homeopathic and drug discovery research and clinical development and has developed homeopathic drugs for the treatment of pain: Cobroxin, an over-the-counter pain reliever designed to treat moderate to severe (Stage II) chronic pain; Nyloxin and Nyloxin Extra Strength, stronger versions of Cobroxin, and Pet Pain-Away, an over-the-counter pain reliever designed to treat pain in cats and dogs.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ellis Scott